)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Peptonic Medical
Peptonic Medical (PMED) investor relations material
Peptonic Medical Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary19 Aug, 2026
Executive summary
Sales of goods decreased by 52% to 2,360 KSEK in Q2 2026 compared to Q2 2025, with a gross margin of 60% versus 97% last year.
Operating loss widened slightly to -3,711 KSEK in Q2 2026 from -3,489 KSEK in Q2 2025.
Strategic focus sharpened post-restructuring, with reduced cost base and new product launches supporting growth ambitions.
First commercial delivery to a US partner marks a milestone in international expansion.
Financial highlights
Q2 2026 sales: 2,360 KSEK (down from 4,912 KSEK in Q2 2025); H1 2026 sales: 5,498 KSEK (down from 8,670 KSEK in H1 2025).
Gross profit in Q2 2026: 1,415 KSEK (Q2 2025: 4,783 KSEK); gross margin 60% (Q2 2025: 97%).
Operating expenses in Q2 2026: -6,577 KSEK, down 32% year-over-year.
Net result for Q2 2026: -3,837 KSEK (Q2 2025: -3,535 KSEK).
Cash at June 30, 2026: 758 KSEK (June 30, 2025: 5,667 KSEK).
Outlook and guidance
Focus remains on product development, sales growth, and brand building.
Updated CE marking for Vernivia expected in autumn, enabling relaunch.
Strengthened financial position and lower cost base support continued commercial development.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Peptonic Medical
- Operating loss narrowed and gross margin improved in Q1 2026 after restructuring and new product launches.PMED
Q1 2026 - Restructuring and cost control drove profitability gains amid lower sales and international expansion.PMEDQ4 2025
- Restructuring led to lower sales but improved cost efficiency; new US/UK deal boosts outlook.PMEDQ3 2025
- Cost cuts and margin gains halved losses, with break-even targeted for November 2025.PMEDQ2 2025
- Revenue declined but gross margin and Nordic sales improved as US direct launch began.PMEDQ3 2024
- Nordic sales surged 60% while group revenue fell; liquidity boosted by post-period rights issue.PMEDQ2 2024
- Restructuring and new launches drive Peptonic's Q1, with improved margins despite lower sales.PMEDQ1 2025
- Nordic sales up 76% and US launch underway, with improved margins and new financing secured.PMEDQ4 2024
Next Peptonic Medical earnings date
Q3 202626 Nov, 2026
Peptonic Medical
Next Peptonic Medical earnings date
Q3 202626 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Peptonic Medical AB is a Sweden-based company specializing in the development and commercialization of products for women's health. The company focuses on medical devices and self-care products, primarily targeting conditions related to vaginal health. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Spotlight Stock Market.